Investments for Proteomics Research in Biotechnology Aids Growth in Western Blotting Market: FMI Study

The global western blotting market is estimated to grow with a healthy 6% CAGR from 2021 to 2031 aided by investments in the pharmaceutical and biotech sectors into protein research dynamics. The overall demand for western blotting can be attributed to use in the field of molecular biology and its contributions to the medical diagnostics sector. Efforts towards research in the field of agriculture and biotechnology for improving crop yields, will also prove to be a lucrative niche for market players in the coming decade.

“The rising number of research activities and spending by biotech and pharmaceutical companies, increasing prevalence of HIV/AIDS cases, and investments into the proteomics market are key factors driving the demand for western blotting products, and their contributions to personalized medicine,” says the FMI study.

Western Blotting Market – Leading Takeaways

  • Improvements to imaging software for handling scan results will generate lucrative opportunities in processes.
  • Widespread prevalence of HIV/AIDS cases globally is a major demand driver for western blotting assays.
  • Investments by pharmaceutical and biotechnology players towards diagnostic tools supports market growth.

Western Blotting Market – Constraints

  • Competition from alternative analytic technologies is a major challenge hindering adoption of western blotting.
  • Western blotting techniques lack high levels of accuracy and provide only approximate values limiting scope of use.

Expected Impact on Market by Coronavirus Outbreak

The covid-19 pandemic hurt short term growth in the global western blotting market in 2019 and 2020. This can be attributed to restrictions on the production of associated products owing to a lack of adequate manpower and disruptions to supplies of essential raw materials. Reduced demand in research applications hurt sales in 2020.

On the other hand, 2021 is expected to display a steady recovery of the sector with relaxations on lockdown regulations and diversification of global supply chains. The potential for applications in the food & beverage sector will aid growth in the coming decade. Further, steady demand for consumables including reagents will aid revenue generation for the foreseeable future.

Explore data on the western blotting market with 86 figures, 22 tables and the ToC. You will also find market segmentation on https://www.futuremarketinsights.com/reports/sample/rep-gb-1050

Competition Landscape

Some of the more prominent manufacturers operating in the western blotting market are Advansta Inc., Thermo Fisher Scientific Inc., Bio-Techne Corporation, GE Healthcare, LI-COR Inc., Hofmann-La Roche Ltd., PerkinElmer Inc., Danaher Corporation, Bio-Rad Laboratories Inc., and EMD Milipore Corporation among others.

Leading market players in the western blotting market are taking efforts towards research and development initiatives towards product development and widening the scope of applications in medical diagnostics.

Bio-Rad Laboratories announced the launch of the Bio-Rad Western Blotting Learning Center, an online repository for detailed information on experimental western blotting approaches including techniques, best practices, and guidance for troubleshooting. Biorbyt unveiled the LYPLA3 antibody codenamed orb185108-Biotin for western blotting testing. Simple Western displayed a multi-antigen serology assay including individual human samples for SARS-CoV-2 immune response analysis in November 2020.

More on the Report

FMI’s provides in-depth insights on the western blotting market. The market is segmented in terms of product type (electrophoresis blotting systems and reagent kits), application (research diagnostics, agricultural, food & beverages, and others), and end user (diagnostic laboratories, research institutions, and pharmaceutical & biotechnology companies), across seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

3D Bioprinting Market: Find insights on the 3D bioprinting market with detailed analysis of statistics, segments, players, influencers, and business strategies adopted over a 10-year forecast period.

HDL Cholesterol Kits Market: FMI’s report on the HDL cholesterol kits market provides insights on the market for 2019-2029. The study discusses revenue sources, restraining forces, market leaders, and market strategies.

HIV/HBV/HCV Test Kits Market: An analysis on the HIV/HBV/HCV test kits market with data on growth levers, opportunities, restraints, regional markets, regulatory policies, and strengths of market leaders.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative

Leave a comment

Your email address will not be published. Required fields are marked *